Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1141720140020020004
Æó¼â¼ºÆóÁúȯ
2014 Volume.2 No. 2 p.4 ~ p.4
New Inhalers for COPD
Moon Ji-Yong

Kim Tae-Hyung
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and chronic inflammation that is not limited in the lung. The mainstay of current treatment for COPD is long-acting bronchodilators. Despite of the unmet needs for anti-inflammatory drugs, the major advances in the bronchodilators are a number of once per day inhaled beta2-agonists, muscarinic antagonists and their combinations. A number of novel inhalers have been investigated for clinical utility on the treatment of COPD. This review will summarize current developments in the field.
KEYWORD
Pulmonary disease, Chronic obstructive, Metered dose inhalers, Dry powder inhalers
FullTexts / Linksout information
Listed journal information